Literature DB >> 15215697

Correlates of engaging in unprotected sex while experiencing dysuria or discharge: a study of men with confirmed gonorrhea.

Richard A Crosby1, Nicole Liddon, Frederick A Martich, Toye Brewer.   

Abstract

OBJECTIVES: To identify the prevalence and correlates of engaging in unprotected sex while experiencing symptoms of gonorrhea among a sample of men with a laboratory confirmed diagnosis.
METHODS: Cross-sectional interview data were analyzed from 237 men, reporting dysuria or discharge, with a laboratory-confirmed diagnosis of gonorrhea.
RESULTS: A total of 21.1% reported engaging in unprotected sex while having symptoms. In multivariate analyses, men engaging in sex > or = 5 times in the past 30 days were 3.5 times more likely to report unprotected sex while symptomatic (P = 0.001). Men reporting condom use < or = 50% of the time (past month) were 2.7 times more likely to report the risk behavior under investigation (P = 0.008). Men never having a previous STD were 2.7 times more likely to engage in the risk behavior (P = 0.006).
CONCLUSIONS: The prevalence of this risk behavior was markedly lower compared to a recent study that was not restricted to gonorrhea. Counseling protocols specifically designed for men who continue to engage in unprotected sex after experiencing gonorrhea-related dysuria and discharge may be valuable for preventing the transmission of gonorrhea to women.

Entities:  

Mesh:

Year:  2004        PMID: 15215697     DOI: 10.1097/01.olq.0000130534.12309.2c

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  2 in total

1.  High-risk sexual behaviour in men attending a sexually transmitted infection clinic in Durban, South Africa.

Authors:  N O'Farrell; L Morison; P Moodley; K Pillay; T Vanmali; M Quigley; A W Sturm
Journal:  Sex Transm Infect       Date:  2007-10-30       Impact factor: 3.519

2.  Syndromic management and STI control in urban Peru.

Authors:  Jesse L Clark; Andres G Lescano; Kelika A Konda; Segundo R Leon; Franca R Jones; Jeffrey D Klausner; Thomas J Coates; Carlos F Caceres
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.